Your browser doesn't support javascript.
An Epidemiological Study of Covid-19 Cases Admitted in a Dedicated Covid Hospital during Second Wave of Corona Pandemic in Central India
Asian Journal of Pharmaceutical and Clinical Research ; 15(12):118-121, 2022.
Article in English | EMBASE | ID: covidwho-2205060
ABSTRACT

Objective:

The objective of the study was to find out any peculiarities in the epidemiological and clinical profiles of COVID-19 cases, admitted in the hospital;which may be useful in management of health services in future. Method(s) Retrospective analysis of hospital records of COVID-19 cases admitted from March to May 2021 in our COVID hospital. A total of 1332 hospital case records were analyzed. Result(s) Out of 1332 admitted COVID-19 cases, 50% were in age group 40-60 years. About 60% cases were male. Symptoms were fever (88.29%), sore throat (70.64%), breathlessness (58.84%), loss of smell (58.82%), pain in abdomen (53%), loss of taste (35.29%), and diarrhea (29.43%). Most cases had multiple symptoms. About 60% cases came in serious condition. About 65% cases needed intensive care unit admission. About 50% cases expired. Conclusion(s) Only peculiarity noticed in clinical profile was loss of taste and sense of smell in few cases. Preponderance of males in the age group of 40-60 years and high mortality among the admitted cases was only peculiar epidemiological feature. Copyright © 2022 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http//creativecommons.org/licenses/by/4.0/)
Keywords

Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Observational study Language: English Journal: Asian Journal of Pharmaceutical and Clinical Research Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Observational study Language: English Journal: Asian Journal of Pharmaceutical and Clinical Research Year: 2022 Document Type: Article